Intro

This chapter analyzes January's financial landscape, focusing on Apple's positive stock performance alongside an anticipated recovery in iPhone sales. It also addresses President Trump's impending tariffs and the FDA's approval of a new non-opioid painkiller, which could reshape the pharmaceutical market.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app